Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M.R., Murphy, B.R., Rappuoli, R., and Lanzavecchia, A.: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 2004, 10:871–875.
Winter, G., Griffiths, A.D., Hawkins, R.E., and Hoogenboom, H.R.: Making antibodies by phage display technology. Annu. Rev. Immunol. 1994, 12:433–455.
16-6 Monoclonal antibodies can be used to prevent allograft rejection.
Kirk, A.D., Burkly, L.C., Batty, D.S., Baumgartner, R.E., Berning, J.D., Buchanan, K., Fechner, J.H., Jr, Germond, R.L., Kampen, R.L., Patterson, N.B., et al.: Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 1999, 5:686–693.
Li, X.C., Strom, T.B., Turka, L.A., and Wells, A.D.: T-cell death and transplantation tolerance. Immunity 2001, 14:407–416.
Londrigan, S.L., Sutherland, R.M., Brady, J.L., Carrington, E.M., Cowan, P.J., d’Apice,A.J.,O’Connell,P.J.,Zhan,Y.,and Lew,A.M.: In situ protection against islet allograft rejection by CTLA4Ig transduction. Transplantation 2010, 90:951–957.
Masharani, U.B., and Becker, J.: Teplizumab therapy for type 1 diabetes. Expert Opin. Biol. Ther. 2010, 10:459–465.
Pham, P.T., Lipshutz, G.S., Pham, P.T., Kawahji, J., Singer, J.S., and Pham, P.C.: The evolving role of alemtuzumab (Campath-1H) in renal transplantation. Drug Des. Dev. Ther. 2009, 3:41–49.
Sageshima, J., Ciancio, G., Chen, L., and Burke, G.W.: Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation. Biologics 2009, 3:319–336.
16-7 Depletion of autoreactive lymphocytes can treat autoimmune disease.
Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., et al.: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N. Engl. J. Med. 2002, 346:235–242.
References.
Coles, A., Deans, J., and Compston, A.: Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench. Clin. Neurol. Neurosurg. 2004, 106:270–274.